For US Healthcare Professionals Only

The JADA<sup>®</sup> System The JADA<sup>®</sup> System
Video ThumbnailPlay

How JADA Works

The JADA® System Uses Vacuum to Induce Physiologic Contraction of the Uterus

The majority of postpartum hemorrhage cases are caused by uterine atony.

Fast, Physiologic Control of Abnormal Postpartum Uterine Bleeding

The JADA System is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted.

Diagram of the JADA® System Device Utilizing Low-Level Vacuum

The JADA System with Low-level Vacuum Connected

The uterus is composed of a web-like network of muscle fibers in its middle layer, called the myometrium. When the placenta separates from the uterine wall after childbirth, that portion of the myometrium is left with open blood vessels, resulting in bleeding. Typically, the uterus contracts and compression of those open vessels stops bleeding. In some instances, the uterine muscle fibers do not contract, causing uncontrolled bleeding, referred to as abnormal postpartum uterine bleeding or postpartum hemorrhage.
Diagram of the JADA® System Device Inserted Into Uterus to Induce Contractions

Uterine Contraction with the JADA System

When connected to a low-level vacuum source (80 mm Hg +/- 10 mm Hg; not to exceed 90 mm Hg), JADA establishes a vacuum within the uterus, causing the uterus to contract and leading to control of the bleeding. In a clinical study (n=107), contraction of the uterus was observed in a median of 1 minute with control of bleeding observed in a median of 3 minutes.1

Innovation That Works

JADA is made of silicone. A survey found that it is easy to use (98%, n=105/107).1

An Intrauterine Loop has interior Vacuum Pores inside a protective Shield to evacuate blood.

An expandable Cervical Seal is filled with sterile fluid to create a seal that holds a vacuum within the uterus.

A connector at the end of the tube is attached to a regulated vacuum source.

Before using JADA, please read the contraindications, warnings, precautions, and other important information in the accompanying Instructions for Use.

Read the PEARLE Study

Get in Touch

If you are a healthcare professional interested in bringing JADA to your facility, click below to be contacted by the representative in your area.

Get JADA
Visit us online
Home Clinical Evidence

Indications, Contraindications, and Warnings

Indications for Use

The JADA® System is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted.

 

Contraindications

  • Ongoing intrauterine pregnancy
  • Untreated uterine rupture
  • Unresolved uterine inversion
  • Current cervical cancer
  • Known uterine anomaly
  • Current purulent infection of vagina, cervix, or uterus
  • For C-sections: Cervix <3 cm dilated before use of JADA

 

Warnings

  • Avoid excessive force when inserting JADA into the uterus or trauma to uterine wall may occur, including perforation.
  • The safety and effectiveness of the JADA System in delivery at a gestational age <34 weeks or, if multiples, uterus judged <34 weeks size, have not been established. With smaller uterine size, there is potential for increased risk of perforation and expulsion.
  • Signs of patient deterioration or failure to improve indicate the need for reassessment and possibly more aggressive treatment and management of postpartum hemorrhage (PPH)/abnormal postpartum uterine bleeding.
  • JADA is not a substitute for surgical management and fluid resuscitation of life-threatening PPH/abnormal postpartum uterine bleeding.
  • Remove air from Cervical Seal prior to device use to minimize risk of air embolism if Cervical Seal bursts.
  • Always fill the Cervical Seal with sterile fluid. Never inflate with air, carbon dioxide, or any other gas to minimize risk of air embolism if Cervical Seal bursts.

To report an adverse event or product quality complaint for JADA, please call 844-JADAMOM.

For general inquiries or to connect with a JADA Rep: jadainfo@organon.com

For existing customer support: USDirectCS@organon.com

Reference

1. D’Alton ME, Rood KM, Smid MC, et al. Intrauterine vacuum-induced hemorrhage-control device for rapid treatment of postpartum hemorrhage. Obstet Gynecol. 2020;136(5):882-891. doi:10.1097/AOG.0000000000004138